FR2205333A1 - 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents - Google Patents

6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents

Info

Publication number
FR2205333A1
FR2205333A1 FR7339363A FR7339363A FR2205333A1 FR 2205333 A1 FR2205333 A1 FR 2205333A1 FR 7339363 A FR7339363 A FR 7339363A FR 7339363 A FR7339363 A FR 7339363A FR 2205333 A1 FR2205333 A1 FR 2205333A1
Authority
FR
France
Prior art keywords
phenanthridone
retion
gastric
inhibitors
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7339363A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Publication of FR2205333A1 publication Critical patent/FR2205333A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Abstract

Title cpds. are of formula: (where n is 0 or 1, and R' is H when n is 0, and is H or CH3 when n is 1) together with their therapeutically acceptable salts. They may be prepd. by acetylating methyl 2-amino-biphenyl-4-carboxylates or 4-acetates, treating the acetyl derivs. with POCl3, hydrolysing the resulting methyl 6-methyl-phenanthridine-3-carboxylates or 3-acetates to the corresp. acids, and oxidising them with CrO3 to form the 6-phenanthridone acids.
FR7339363A 1972-11-06 1973-11-06 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents Withdrawn FR2205333A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3131972 1972-11-06

Publications (1)

Publication Number Publication Date
FR2205333A1 true FR2205333A1 (en) 1974-05-31

Family

ID=11233456

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339363A Withdrawn FR2205333A1 (en) 1972-11-06 1973-11-06 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents

Country Status (7)

Country Link
JP (1) JPS49133376A (en)
BE (1) BE806984A (en)
DE (1) DE2355084A1 (en)
FR (1) FR2205333A1 (en)
IL (1) IL44001A0 (en)
NL (1) NL7315191A (en)
ZA (1) ZA738479B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011624A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089426B1 (en) * 1979-07-12 1986-06-11 A.H. Robins Company, Incorporated 2-amino-6-biphenylacetic acids
CA2546657C (en) * 2003-12-05 2013-05-14 Janssen Pharmaceutica N.V. 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
ES2528316T3 (en) * 2006-09-01 2015-02-06 Senhwa Biosciences, Inc. Serine-threonine protein kinase and PARP modulators

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011624A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
US6306889B1 (en) 1997-09-03 2001-10-23 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6380211B1 (en) 1997-09-03 2002-04-30 Guilford Pharmaceutical Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6716828B1 (en) 1999-09-01 2004-04-06 Guilford Pharmaceuticals, Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
US6348475B1 (en) 2000-06-01 2002-02-19 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
NL7315191A (en) 1974-05-08
DE2355084A1 (en) 1974-05-16
BE806984A (en) 1974-03-01
ZA738479B (en) 1974-11-27
JPS49133376A (en) 1974-12-21
IL44001A0 (en) 1974-05-16

Similar Documents

Publication Publication Date Title
FR2205333A1 (en) 6-Phenanthridone-3-carboxylic or-acetic acids - useful as gastric sec-retion inhibitors and anti-ulcer agents
GB1383083A (en) Thiazolidine derivatives
ES415514A1 (en) Sweet and palatable water soluble derivatives of erythromycin
GB1250558A (en)
ES380932A1 (en) Halophenylpyrimidine carboxylic acids
FR2160246A1 (en) Tannin/methylcellulose compsns - dermatological antiseptics
FR2054955A5 (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
NL7010194A (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
BE753153A (en) Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn
GB1296655A (en)
JPS53126063A (en) Production of chitin derivative
FR2160719A1 (en) Benzimidazolyl propanol derivs - respiratory analeptics spasmolytics analgesics antiinflammatories vasodilators and hypotensi
FR2154326A1 (en) (7' or 8' chloro-4-quinolinyl)-2-amino-nicotinic acid derivs - - analgesic,antiinflammatory
IE36982L (en) Penicillamine preparation
GB1241839A (en) Pyridinium compounds
FR2120600A5 (en) Acetyl and cyanoethyl derivs - of polyvinyl acetate used as adhesives
FR2152377A1 (en) 1-phenyl-2-methyl-5-alkyl or alkoxy-3-indolylacetic acid - derivs - antiinflammatory, analgesic, antipyretic
FR2160704A2 (en) Esters of spirocyclohexane naphthalene acetic acid - - antiinflammatories and analgesics
FR2132527A1 (en) Salicyl amino indazoles - spasmolytics
ES420666A1 (en) (1-methyl-5-nitro-2-imidazolyl)thioalkanoic acids and derivatives
FR2198735A1 (en) Substd 3-alkyl 2-nitrobenzofurans - by nitration of corresp 2-acyl derivs, used as parasiticides
FR2134121A1 (en) Piperazino ethyl phloroglucates prepn - useful as vasodilators
BE784666A (en) Benzopyran derivs - inters in total steroid synthesis
FR2101148A1 (en) Spiroheterocycloalkane phenyl acetic acid derivs - antiinflammatores and analgesics
FR2168245A1 (en) Dimethylamino ethanol pyridinecarboxylate - cholinergic and antiinflammatory

Legal Events

Date Code Title Description
ST Notification of lapse